Rayzebio

RayzeBio is a biotechnology company focused on developing targeted radiopharmaceuticals for cancer treatment. They make money by advancing their proprietary platform to create novel radiopharmaceutical therapies that precisely target and destroy cancer cells, which they then commercialize through partnerships and sales. Founded in 2020, RayzeBio has quickly gained attention for its innovative approach, securing significant funding and collaborations with leading research institutions to accelerate the development of its pipeline products.

Recent Posts by Rayzebio

1-18 of 18